PreservCyt Transport Medium Used for the ThinPrep Pap Test Is a Suitable Medium for Detection of Chlamydia trachomatis by the COBAS Amplicor CT/NG Test: Results of a Preliminary Study and Future Implications
Open Access
- 1 May 2002
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (5) , 1749-1754
- https://doi.org/10.1128/jcm.40.5.1749-1754.2002
Abstract
The commercial COBAS Amplicor CT/NG test (Roche Diagnostic Systems, Meylan, France) is a sensitive and specific method for detection of Chlamydia trachomatis infections. This test currently consists of using a nucleic acid amplification method to detect C. trachomatis in first-void urine specimens and in endocervical swabs collected in 2-sucrose-phosphate (2SP) transport medium. We conducted a prospective study to determine whether the automated COBAS Amplicor CT/NG test can detect C. trachomatis in cervical specimens collected in PreservCyt transport medium (ThinPrep Pap Test; Cytyc Corporation, Boxborough, Mass.). PreservCyt medium is used to preserve cervical samples before the preparation of ThinPrep slides. We collected 1,000 cervical specimens from young women (age range, 15 to 25 years) during routine Pap smear tests. Only specimens with normal cytology and in which the gynecologist found no clinical evidence of urogenital infections were selected. The samples were stored in PreservCyt transport medium at 15 to 20°C. C. trachomatis was detected in 22 of the 1,000 cervical specimens that had been stored in PreservCyt. To confirm the positive samples, the test was repeated on new endocervical swab specimens collected in 2SP transport medium. Only 9 of the 22 positive patients agreed to undergo this control, but all 9 retested positive. To evaluate the influence of storage conditions on the sensitivity of the C. trachomatis PCR test, all of the positive samples were stored at 15 to 20°C in PreservCyt transport medium and were retested every 2 weeks for 6 weeks. C. trachomatis was successfully amplified from all 22 specimens for the whole 6-week period. The prevalence of C. trachomatis infection was 2.2% in our study population. These results demonstrate that PreservCyt transport medium is a suitable transport medium for detection of C. trachomatis by the COBAS Amplicor CT/NG test. The ThinPrep Pap Test may enable gynecologists to monitor for both cervical lesions and C. trachomatis infections with a single endocervical specimen.Keywords
This publication has 28 references indexed in Scilit:
- Chlamydia trachomatis and Pap testing from a single, fluid-based sample. A multicenter study.2001
- HPV DNA Testing of the Residual Sample of Liquid-Based Pap Test: Utility as a Quality Assurance MonitorLaboratory Investigation, 2001
- Liquid-based cytology for primary cervical cancer screening: a multi-centre studyBritish Journal of Cancer, 2001
- Characterization of RNA in cytologic samples preserved in a methanol-based collection solution*, **Molecular Diagnosis, 1998
- Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screeningObstetrics & Gynecology, 1997
- Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic studyAmerican Journal of Obstetrics and Gynecology, 1996
- Prevention of Pelvic Inflammatory Disease by Screening for Cervical Chlamydial InfectionNew England Journal of Medicine, 1996
- Decreased Prevalence of Chlamydia trachomatis Infection Associated With a Selective Screening Program in Family Planning Clinics in WisconsinSexually Transmitted Diseases, 1993
- Abnormal cervical cytology in adolescents: A literature reviewJournal of Adolescent Health, 1992
- Advances in nucleic acid-based detection methodsClinical Microbiology Reviews, 1992